Vimta Labs Share Price
645.20-7.05 (-1.08%)
-20.55% past 1 Year
News
Vimta Labs sees strong pharma demand, new biologics facility to lift margins
Equity
VIMTALABS
Vimta Labs sees stable margins ahead despite Q1 operating pressure and costs
Equity
VIMTALABS
Vimta Labs targets 20–25 percent revenue growth for FY27 despite flat Q1 run rate
Equity
VIMTALABS
Vimta Labs posts higher Q1 revenue, EBITDA and PAT on year
Equity
VIMTALABS
Vimta Labs Q1 EBITDA grows year-on-year amid marginal margin compression
Equity
VIMTALABS
Vimta Labs Q1 standalone net profit rises year-on-year to Rs 21 crores
Equity
VIMTALABS
Vimta Labs schedules Q1 FY27 earnings conference call for July 20, 4 pm
Equity
VIMTALABS
Vimta Labs - Quaterly Results
Equity
VIMTALABS
Vimta Labs reports Profit after tax of 21.11 Crores, in the March 2026 quarter
Equity
VIMTALABS
Vimta Labs Recommends Dividend of Rs 2 Per Share.
Equity
VIMTALABS
Vimta Labs Q4 EBITDA Growth Outpaces YoY with Margin Expansion
Equity
VIMTALABS
Vimta Labs Reports Q4 Net Profit of Rs 21.10 Crores, Up YoY from Rs 18.32 Crores
Equity
VIMTALABS
Vimta Labs informs about analyst meet
Equity
VIMTALABS
Vimta Labs - Quaterly Results
Equity
VIMTALABS
Vimta Labs reports Profit after tax of 17.59 Crores, in the December 2025 quarter
Equity
VIMTALABS
Vimta Labs Q3FY25 Net Profit Rises 112.2% YoY to Rs 21.50 Crores.
Equity
VIMTALABS
Vimta Labs Q3 EBITDA at Rs 34.20 Crores, Up Slightly YoY; Margin Contracts to 34.7%.
Equity
VIMTALABS
Vimta Labs - Quaterly Results
Equity
VIMTALABS
Vimta Labs reports Profit after tax of 19.92 Crores, in the September 2025 quarter
Equity
VIMTALABS
Vimta Labs reports Q2 EBITDA growth but margin moderates, YoY performance released.
Equity
VIMTALABS